Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
31
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Eckler Matthew Joseph | Director | 1 | $0 | $0 | 2026-10-01 |
| FLOWERS KIRSTEN | Director | 6 | $0 | $0 | 2026-06-04 |
| Stelzer Laurie | Director | 6 | $0 | $0 | 2026-06-04 |
| BAUM CHARLES M | Director | 7 | $0 | $0 | 2026-06-04 |
| Gallagher Carol Giltner | Director | 15 | $0 | $0 | 2026-06-04 |
| LEVINE ARNOLD J | Director | 14 | $0 | $568.3K | 2026-06-04 |
| Carulli Michael | Chief Financial Officer | 11 | $0 | $34.3K | 2026-03-05 |
| Jalota Deepika | SVP, Regulatory Affairs and QA | 19 | $0 | $170.9K | 2026-03-05 |
| Ticktin Robert | General Counsel & COO | 2 | $0 | $24.5K | 2026-03-05 |
| Mack David Henry | President and CEO | 56 | $0 | $1.56M | 2026-03-05 |
| OrbiMed Capital GP V LLC | 10% Owner | 2 | $0 | $1.94M | 2025-10-23 |
| ORBIMED ADVISORS LLC | Director, 10% Owner | 13 | $17.10M | $900.0K | 2025-09-10 |
| Heyman Richard A. | Director | 22 | $0 | $126.9K | 2025-06-05 |
| OrbiMed Genesis GP LLC | 10% Owner | 4 | $0 | $10.46M | 2023-11-22 |
| Alland Leila | Chief Medical Officer | 32 | $0 | $853.2K | 2023-09-15 |
| Kung Winston | COO, CFO | 23 | $0 | $607.8K | 2023-05-12 |
| Thompson Peter A. | Director, 10% Owner | 13 | $17.10M | $0 | 2022-06-02 |
| Schroeder Thilo | Director, 10% Owner | 101 | $0 | $38.34M | 2021-10-06 |
| Kliman Gilbert H | 10% Owner | 15 | $1000.0K | $0 | 2021-07-13 |
| Greenland A LLC | 10% Owner | 10 | $0 | $2.26M | 2021-06-14 |
| Greenland NFP LLC | 10% Owner | 10 | $0 | $2.01M | 2021-06-10 |
| Simons Marilyn | 10% Owner | 10 | $0 | $2.09M | 2021-06-08 |
| Desai Keval | 10% Owner | 6 | $0 | $0 | 2021-05-10 |
| InterWest Management Partners X, LLC | 10% Owner | 6 | $0 | $0 | 2021-03-24 |
| Lips Thomas | Other | 4 | $0 | $0 | 2020-09-29 |
| Chhabra Ashvin | Other | 8 | $0 | $0 | 2020-09-29 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Other | 2 | $0 | $0 | 2020-09-29 |
| Boxer Asset Management Inc. | Other | 9 | $17.10M | $0 | 2020-09-29 |
| INTERWEST PARTNERS X LP | 10% Owner | 9 | $990.0K | $0 | 2020-09-29 |
| Kolchinsky Peter | 10% Owner | 3 | $17.10M | $0 | 2020-09-29 |
| ORONSKY ARNOLD L | Director, 10% Owner | 18 | $1.99M | $0 | 2020-09-29 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Eckler Matthew Joseph | Director | A Award deriv | 2026-10-01 | 2026-10-05 | 84,000 | — | $0 | 84,000 | SEC↗ |
| BAUM CHARLES M | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 42,000 | — | $0 | 42,000 | SEC↗ |
| FLOWERS KIRSTEN | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Gallagher Carol Giltner | Director | G Gift deriv | 2026-06-04 | 2026-06-05 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Gallagher Carol Giltner | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Gallagher Carol Giltner | Director | G Gift deriv | 2026-06-04 | 2026-06-05 | 42,000 | — | $0 | 0 | SEC↗ |
| LEVINE ARNOLD J | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Stelzer Laurie | Director | A Award deriv | 2026-06-04 | 2026-06-05 | 42,000 | — | $0 | 42,000 | SEC↗ |
| Mack David Henry | President and CEO | A Award deriv | 2026-03-05 | 2026-03-09 | 744,960 | — | $0 | 744,960 | SEC↗ |
| Jalota Deepika | Chief Development Officer | A Award deriv | 2026-03-05 | 2026-03-09 | 303,310 | — | $0 | 303,310 | SEC↗ |
| Ticktin Robert | General Counsel & COO | A Award deriv | 2026-03-05 | 2026-03-09 | 319,270 | — | $0 | 319,270 | SEC↗ |
| Carulli Michael | Chief Financial Officer | A Award deriv | 2026-03-05 | 2026-03-09 | 240,000 | — | $0 | 240,000 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise deriv | 2025-10-27 | 2025-10-29 | 220,643 | — | $0 | 0 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise | 2025-10-27 | 2025-10-29 | 220,643 | $1.37 | $302.3K | 451,109 | SEC↗ |
| OrbiMed Capital GP V LLC | 10% Owner | S Sale | 2025-10-23 | 2025-10-27 | 1,000,000 | $1.52 | $1.52M | 4,975,291 | SEC↗ |
| ORBIMED ADVISORS LLC | 10% Owner | S Sale | 2025-09-10 | 2025-09-12 | 500,000 | $1.80 | $900.0K | 5,975,291 | SEC↗ |
| Mack David Henry | President and CEO | S Sale | 2025-07-01 | 2025-07-03 | 58,411 | $1.06 | $61.9K | 536,133 | SEC↗ |
| Carulli Michael | Chief Financial Officer | S Sale | 2025-07-01 | 2025-07-03 | 28,249 | $1.06 | $29.9K | 60,146 | SEC↗ |
| Jalota Deepika | Chief Development Officer | S Sale | 2025-07-01 | 2025-07-03 | 33,065 | $1.06 | $35.0K | 89,959 | SEC↗ |
| Ticktin Robert | General Counsel & COO | S Sale | 2025-07-01 | 2025-07-03 | 23,151 | $1.06 | $24.5K | 98,695 | SEC↗ |
| BAUM CHARLES M | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 33,500 | — | $0 | 33,500 | SEC↗ |
| FLOWERS KIRSTEN | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 33,500 | — | $0 | 33,500 | SEC↗ |
| Gallagher Carol Giltner | Director | G Gift deriv | 2025-06-05 | 2025-06-09 | 33,500 | — | $0 | 0 | SEC↗ |
| Gallagher Carol Giltner | Director | G Gift deriv | 2025-06-05 | 2025-06-09 | 33,500 | — | $0 | 33,500 | SEC↗ |
| Gallagher Carol Giltner | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 33,500 | — | $0 | 33,500 | SEC↗ |
| Heyman Richard A. | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 33,500 | — | $0 | 33,500 | SEC↗ |
| LEVINE ARNOLD J | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 33,500 | — | $0 | 33,500 | SEC↗ |
| Stelzer Laurie | Director | A Award deriv | 2025-06-05 | 2025-06-09 | 33,500 | — | $0 | 33,500 | SEC↗ |
| Mack David Henry | President and CEO | A Award deriv | 2025-03-03 | 2025-03-05 | 800,000 | — | $0 | 800,000 | SEC↗ |
| Jalota Deepika | Chief Development Officer | A Award deriv | 2025-03-03 | 2025-03-05 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Carulli Michael | Chief Financial Officer | A Award deriv | 2025-03-03 | 2025-03-05 | 265,000 | — | $0 | 265,000 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise deriv | 2025-01-03 | 2025-01-22 | 17,709 | — | $0 | 0 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise | 2025-01-03 | 2025-01-22 | 17,709 | $0.53 | $9.4K | 551,919 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise deriv | 2024-12-03 | 2025-01-22 | 91,750 | — | $0 | 17,709 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise | 2024-12-03 | 2025-01-22 | 91,750 | $0.53 | $48.6K | 534,210 | SEC↗ |
| Carulli Michael | Chief Financial Officer | S Sale | 2024-09-11 | 2024-09-12 | 2,891 | $1.50 | $4.3K | 88,395 | SEC↗ |
| Jalota Deepika | Chief Development Officer | S Sale | 2024-09-11 | 2024-09-12 | 7,218 | $1.50 | $10.8K | 118,283 | SEC↗ |
| Mack David Henry | President and CEO | D To issuer deriv | 2024-08-13 | 2024-10-03 | 330,000 | — | $0 | 0 | SEC↗ |
| Mack David Henry | President and CEO | D To issuer deriv | 2024-08-13 | 2024-10-03 | 134,584 | — | $0 | 0 | SEC↗ |
| Mack David Henry | President and CEO | D To issuer deriv | 2024-08-13 | 2024-10-03 | 249,600 | — | $0 | 0 | SEC↗ |
| Mack David Henry | President and CEO | A Award deriv | 2024-08-13 | 2024-10-03 | 330,000 | — | $0 | 330,000 | SEC↗ |
| Mack David Henry | President and CEO | A Award deriv | 2024-08-13 | 2024-10-03 | 384,184 | — | $0 | 384,184 | SEC↗ |
| Carulli Michael | Chief Financial Officer | D To issuer deriv | 2024-08-13 | 2024-10-03 | 27,200 | — | $0 | 0 | SEC↗ |
| Carulli Michael | Chief Financial Officer | D To issuer deriv | 2024-08-13 | 2024-10-03 | 13,605 | — | $0 | 0 | SEC↗ |
| Carulli Michael | Chief Financial Officer | D To issuer deriv | 2024-08-13 | 2024-10-03 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Carulli Michael | Chief Financial Officer | A Award deriv | 2024-08-13 | 2024-10-03 | 75,000 | — | $0 | 75,000 | SEC↗ |
| Carulli Michael | Chief Financial Officer | A Award deriv | 2024-08-13 | 2024-10-03 | 40,805 | — | $0 | 40,805 | SEC↗ |
| Jalota Deepika | Chief Development Officer | D To issuer deriv | 2024-08-13 | 2024-10-03 | 68,100 | — | $0 | 0 | SEC↗ |
| Jalota Deepika | Chief Development Officer | D To issuer deriv | 2024-08-13 | 2024-10-03 | 22,674 | — | $0 | 0 | SEC↗ |
| Jalota Deepika | Chief Development Officer | D To issuer deriv | 2024-08-13 | 2024-10-03 | 125,000 | — | $0 | 0 | SEC↗ |
| Jalota Deepika | Chief Development Officer | A Award deriv | 2024-08-13 | 2024-10-03 | 90,774 | — | $0 | 90,774 | SEC↗ |
| Jalota Deepika | Chief Development Officer | A Award deriv | 2024-08-13 | 2024-10-03 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Gallagher Carol Giltner | Director | G Gift deriv | 2024-06-07 | 2024-06-10 | 67,500 | — | $0 | 0 | SEC↗ |
| Gallagher Carol Giltner | Director | G Gift deriv | 2024-06-07 | 2024-06-10 | 67,500 | — | $0 | 67,500 | SEC↗ |
| BAUM CHARLES M | Director | A Award deriv | 2024-06-06 | 2024-06-10 | 67,500 | — | $0 | 67,500 | SEC↗ |
| FLOWERS KIRSTEN | Director | A Award deriv | 2024-06-06 | 2024-06-10 | 67,500 | — | $0 | 67,500 | SEC↗ |
| Gallagher Carol Giltner | Director | A Award deriv | 2024-06-06 | 2024-06-10 | 67,500 | — | $0 | 67,500 | SEC↗ |
| Heyman Richard A. | Director | A Award deriv | 2024-06-06 | 2024-06-10 | 67,500 | — | $0 | 67,500 | SEC↗ |
| LEVINE ARNOLD J | Director | A Award deriv | 2024-06-06 | 2024-06-10 | 67,500 | — | $0 | 67,500 | SEC↗ |
| Stelzer Laurie | Director | A Award deriv | 2024-06-06 | 2024-06-10 | 67,500 | — | $0 | 67,500 | SEC↗ |
| Mack David Henry | President and CEO | A Award deriv | 2024-01-18 | 2024-01-22 | 519,915 | — | $0 | 519,915 | SEC↗ |
| Carulli Michael | Chief Financial Officer | A Award deriv | 2024-01-18 | 2024-01-22 | 204,630 | — | $0 | 204,630 | SEC↗ |
| Jalota Deepika | Chief Development Officer | A Award deriv | 2024-01-18 | 2024-01-22 | 225,095 | — | $0 | 225,095 | SEC↗ |
| Mack David Henry | President and CEO | A Award | 2024-01-18 | 2024-01-22 | 163,890 | — | $0 | 442,460 | SEC↗ |
| Carulli Michael | Chief Financial Officer | A Award | 2024-01-18 | 2024-01-22 | 82,220 | — | $0 | 91,286 | SEC↗ |
| Jalota Deepika | Chief Development Officer | A Award | 2024-01-18 | 2024-01-22 | 95,555 | — | $0 | 125,501 | SEC↗ |
| OrbiMed Genesis GP LLC | 10% Owner | S Sale | 2023-11-22 | 2023-11-24 | 87,786 | $2.23 | $195.8K | 0 | SEC↗ |
| Mack David Henry | President and CEO | G Gift | 2023-11-10 | 2023-11-13 | 85,307 | — | $0 | 165,307 | SEC↗ |
| Mack David Henry | President and CEO | G Gift | 2023-11-10 | 2023-11-13 | 85,307 | — | $0 | 278,570 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise | 2023-10-18 | 2023-11-13 | 198,407 | $0.53 | $105.2K | 363,877 | SEC↗ |
| Alland Leila | Chief Medical Officer | S Sale | 2023-09-15 | 2023-09-18 | 6,291 | $6.62 | $41.6K | 45,909 | SEC↗ |
| Jalota Deepika | Chief Development Officer | S Sale | 2023-09-15 | 2023-09-18 | 4,104 | $6.62 | $27.2K | 29,946 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise deriv | 2023-08-07 | 2023-11-13 | 198,407 | — | $0 | 109,459 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise deriv | 2023-08-07 | 2023-08-08 | 85,500 | — | $0 | 307,866 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise | 2023-08-07 | 2023-08-08 | 85,500 | $0.53 | $45.3K | 165,470 | SEC↗ |
| BAUM CHARLES M | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 21,500 | — | $0 | 21,500 | SEC↗ |
| FLOWERS KIRSTEN | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 21,500 | — | $0 | 21,500 | SEC↗ |
| Gallagher Carol Giltner | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 21,500 | — | $0 | 21,500 | SEC↗ |
| Gallagher Carol Giltner | Director | G Gift deriv | 2023-06-08 | 2023-06-12 | 21,500 | — | $0 | 21,500 | SEC↗ |
| Gallagher Carol Giltner | Director | G Gift deriv | 2023-06-08 | 2023-06-12 | 21,500 | — | $0 | 0 | SEC↗ |
| Heyman Richard A. | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 21,500 | — | $0 | 21,500 | SEC↗ |
| LEVINE ARNOLD J | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 21,500 | — | $0 | 21,500 | SEC↗ |
| Stelzer Laurie | Director | A Award deriv | 2023-06-08 | 2023-06-12 | 21,500 | — | $0 | 21,500 | SEC↗ |
| Mack David Henry | President and CEO | A Award deriv | 2023-05-12 | 2023-05-15 | 330,000 | — | $0 | 330,000 | SEC↗ |
| Kung Winston | COO, CFO | A Award deriv | 2023-05-12 | 2023-05-15 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Alland Leila | Chief Medical Officer | A Award deriv | 2023-05-12 | 2023-05-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Jalota Deepika | Chief Development Officer | A Award deriv | 2023-05-12 | 2023-05-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Kung Winston | COO, CFO | G Gift | 2022-11-25 | 2023-01-30 | 2,560 | — | $0 | 10,600 | SEC↗ |
| Gallagher Carol Giltner | Director | G Gift deriv | 2022-11-05 | 2022-11-08 | 39,000 | — | $0 | 39,000 | SEC↗ |
| Gallagher Carol Giltner | Director | G Gift deriv | 2022-11-05 | 2022-11-08 | 39,000 | — | $0 | 39,000 | SEC↗ |
| Gallagher Carol Giltner | Director | A Award deriv | 2022-11-04 | 2022-11-08 | 39,000 | — | $0 | 39,000 | SEC↗ |
| Alland Leila | Chief Medical Officer | A Award | 2022-09-09 | 2022-09-13 | 52,200 | — | $0 | 52,200 | SEC↗ |
| Jalota Deepika | SVP, Regulatory Affairs and | A Award | 2022-09-09 | 2022-09-13 | 34,050 | — | $0 | 34,050 | SEC↗ |
| BAUM CHARLES M | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 19,500 | — | $0 | 19,500 | SEC↗ |
| FLOWERS KIRSTEN | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 19,500 | — | $0 | 19,500 | SEC↗ |
| Heyman Richard A. | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 19,500 | — | $0 | 19,500 | SEC↗ |
| LEVINE ARNOLD J | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 19,500 | — | $0 | 19,500 | SEC↗ |
| Stelzer Laurie | Director | A Award deriv | 2022-06-02 | 2022-06-06 | 19,500 | — | $0 | 19,500 | SEC↗ |
| Thompson Peter A. | Director, 10% Owner | A Award deriv | 2022-06-02 | 2021-06-09 | 16,333 | — | $0 | 16,333 | SEC↗ |
| OrbiMed Capital GP V LLC | 10% Owner | S Sale | 2022-05-26 | 2022-05-31 | 26,253 | $15.93 | $418.2K | 87,786 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise deriv | 2022-04-27 | 2022-04-29 | 33,000 | — | $0 | 393,366 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise | 2022-04-27 | 2022-04-29 | 33,000 | $0.53 | $17.5K | 79,970 | SEC↗ |
| Kung Winston | COO, CFO | M Exercise deriv | 2022-04-20 | 2022-04-21 | 4,000 | — | $0 | 210,034 | SEC↗ |
| Kung Winston | COO, CFO | M Exercise | 2022-04-20 | 2022-04-21 | 4,000 | $3.22 | $12.9K | 10,600 | SEC↗ |
| OrbiMed Genesis GP LLC | 10% Owner | S Sale | 2022-03-31 | 2022-03-31 | 34,500 | $21.17 | $730.4K | 0 | SEC↗ |
| OrbiMed Genesis GP LLC | 10% Owner | S Sale | 2022-03-30 | 2022-03-31 | 75,000 | $22.39 | $1.68M | 34,500 | SEC↗ |
| OrbiMed Genesis GP LLC | 10% Owner | S Sale | 2022-03-29 | 2022-03-31 | 365,000 | $21.52 | $7.85M | 109,500 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise deriv | 2022-03-08 | 2022-03-09 | 20,000 | — | $0 | 220,644 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise | 2022-03-08 | 2022-03-09 | 20,000 | $1.37 | $27.4K | 46,970 | SEC↗ |
| Mack David Henry | President and CEO | A Award deriv | 2022-02-10 | 2022-02-28 | 249,600 | — | $0 | 249,600 | SEC↗ |
| Kung Winston | COO, CFO | A Award deriv | 2022-02-10 | 2022-02-28 | 104,400 | — | $0 | 104,400 | SEC↗ |
| Alland Leila | Chief Medical Officer | A Award deriv | 2022-02-10 | 2022-02-28 | 104,400 | — | $0 | 104,400 | SEC↗ |
| Jalota Deepika | SVP, Regulatory Affairs and | A Award deriv | 2022-02-10 | 2022-02-28 | 68,100 | — | $0 | 68,100 | SEC↗ |
| FLOWERS KIRSTEN | Director | M Exercise deriv | 2022-01-06 | 2022-01-10 | 32,677 | — | $0 | 32,677 | SEC↗ |
| Kung Winston | COO, CFO | G Gift | 2021-12-30 | 2022-02-08 | 2,725 | — | $0 | 6,600 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise deriv | 2021-12-15 | 2021-12-16 | 9,000 | — | $0 | 432,574 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise | 2021-12-15 | 2021-12-16 | 9,000 | $0.53 | $4.8K | 26,970 | SEC↗ |
| Mack David Henry | President and CEO | G Gift | 2021-12-09 | 2021-12-16 | 40,000 | — | $0 | 187,915 | SEC↗ |
| Mack David Henry | President and CEO | G Gift | 2021-12-09 | 2021-12-16 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-10-06 | 2021-10-08 | 800 | $30.15 | $24.1K | 1,101,283 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-10-04 | 2021-10-04 | 100 | $30.08 | $3.0K | 1,102,083 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-10-01 | 2021-10-04 | 11,541 | $30.10 | $347.4K | 1,102,183 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-09-30 | 2021-10-04 | 2,978 | $30.03 | $89.4K | 1,113,724 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-09-29 | 2021-09-29 | 5,708 | $30.04 | $171.5K | 1,116,702 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-09-27 | 2021-09-29 | 1,753 | $30.11 | $52.8K | 1,122,410 | SEC↗ |
| LEVINE ARNOLD J | Director | S Sale | 2021-09-22 | 2021-09-23 | 3,500 | $30.00 | $105.0K | 409,842 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-09-22 | 2021-09-24 | 100 | $30.00 | $3.0K | 1,124,163 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-09-17 | 2021-09-21 | 711 | $30.03 | $21.4K | 1,124,263 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-09-13 | 2021-09-13 | 13,272 | $30.20 | $400.8K | 1,124,974 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-09-10 | 2021-09-13 | 38,056 | $30.44 | $1.16M | 1,143,417 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-09-10 | 2021-09-13 | 5,171 | $31.03 | $160.5K | 1,138,246 | SEC↗ |
| Alland Leila | Chief Medical Officer | M Exercise deriv | 2021-09-09 | 2021-09-10 | 100 | — | $0 | 353,850 | SEC↗ |
| Alland Leila | Chief Medical Officer | M Exercise | 2021-09-09 | 2021-09-10 | 100 | $3.90 | $390 | 100 | SEC↗ |
| Alland Leila | Chief Medical Officer | S Sale | 2021-09-09 | 2021-09-10 | 100 | $30.25 | $3.0K | 0 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-09-09 | 2021-09-13 | 14,329 | $30.31 | $434.3K | 1,181,473 | SEC↗ |
| Alland Leila | Chief Medical Officer | M Exercise deriv | 2021-09-07 | 2021-09-08 | 3,900 | — | $0 | 353,950 | SEC↗ |
| Alland Leila | Chief Medical Officer | M Exercise | 2021-09-07 | 2021-09-08 | 3,900 | $3.90 | $15.2K | 3,900 | SEC↗ |
| Alland Leila | Chief Medical Officer | S Sale | 2021-09-07 | 2021-09-08 | 3,900 | $30.25 | $118.0K | 0 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-09-02 | 2021-09-02 | 5,400 | $30.15 | $162.8K | 1,195,802 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-09-01 | 2021-09-02 | 21,986 | $30.38 | $667.9K | 1,201,202 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-31 | 2021-09-02 | 19,520 | $30.12 | $587.9K | 1,223,188 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-30 | 2021-08-30 | 13,233 | $30.05 | $397.7K | 1,242,708 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-27 | 2021-08-30 | 1,045 | $31.06 | $32.5K | 1,255,941 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-27 | 2021-08-30 | 23,397 | $30.50 | $713.6K | 1,256,986 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-26 | 2021-08-30 | 6,091 | $31.13 | $189.6K | 1,280,383 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-26 | 2021-08-30 | 15,063 | $30.39 | $457.8K | 1,286,474 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-25 | 2021-08-25 | 13,526 | $31.01 | $419.4K | 1,585,953 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-24 | 2021-08-25 | 14,490 | $31.08 | $450.3K | 1,599,479 | SEC↗ |
| LEVINE ARNOLD J | Director | S Sale | 2021-08-23 | 2021-08-24 | 3,500 | $29.50 | $103.3K | 413,342 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-23 | 2021-08-25 | 700 | $31.06 | $21.7K | 1,613,969 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-23 | 2021-08-25 | 23,138 | $30.66 | $709.4K | 1,614,669 | SEC↗ |
| Kung Winston | COO, CFO | M Exercise deriv | 2021-08-19 | 2021-08-20 | 5,000 | — | $0 | 214,034 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise deriv | 2021-08-19 | 2021-08-20 | 5,500 | — | $0 | 441,574 | SEC↗ |
| Kung Winston | COO, CFO | M Exercise | 2021-08-19 | 2021-08-20 | 5,000 | $3.22 | $16.1K | 6,600 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise | 2021-08-19 | 2021-08-20 | 5,500 | $0.53 | $2.9K | 17,970 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-19 | 2021-08-20 | 3,800 | $30.97 | $117.7K | 1,637,807 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-18 | 2021-08-20 | 13,196 | $33.84 | $446.6K | 1,643,844 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-18 | 2021-08-20 | 2,237 | $34.32 | $76.8K | 1,641,607 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-18 | 2021-08-20 | 11,431 | $32.57 | $372.3K | 1,657,040 | SEC↗ |
| Jalota Deepika | SVP, Regulatory Affairs and | M Exercise deriv | 2021-08-17 | 2021-08-18 | 2,896 | — | $0 | 87,320 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-17 | 2021-08-17 | 15,276 | $33.21 | $507.3K | 1,684,217 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-17 | 2021-08-17 | 15,746 | $33.93 | $534.3K | 1,668,471 | SEC↗ |
| Jalota Deepika | SVP, Regulatory Affairs and | S Sale | 2021-08-17 | 2021-08-18 | 2,896 | $33.78 | $97.8K | 0 | SEC↗ |
| Jalota Deepika | SVP, Regulatory Affairs and | M Exercise | 2021-08-17 | 2021-08-18 | 2,896 | $3.53 | $10.2K | 2,896 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-16 | 2021-08-17 | 2,599 | $34.54 | $89.8K | 1,699,493 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-16 | 2021-08-17 | 19,584 | $33.80 | $661.9K | 1,702,092 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-13 | 2021-08-17 | 25,786 | $34.22 | $882.4K | 1,723,176 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-13 | 2021-08-17 | 1,500 | $34.66 | $52.0K | 1,721,676 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-12 | 2021-08-12 | 11,565 | $34.35 | $397.3K | 1,750,933 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-12 | 2021-08-12 | 1,971 | $34.83 | $68.6K | 1,748,962 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-11 | 2021-08-12 | 34,439 | $34.04 | $1.17M | 1,762,498 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-10 | 2021-08-12 | 17,905 | $34.76 | $622.4K | 1,799,537 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-10 | 2021-08-12 | 2,600 | $35.54 | $92.4K | 1,796,937 | SEC↗ |
| Alland Leila | Chief Medical Officer | M Exercise deriv | 2021-08-09 | 2021-08-10 | 4,000 | — | $0 | 357,850 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-09 | 2021-08-09 | 300 | $36.64 | $11.0K | 1,817,442 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-09 | 2021-08-09 | 13,259 | $35.14 | $465.9K | 1,826,365 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-09 | 2021-08-09 | 8,623 | $36.08 | $311.1K | 1,817,742 | SEC↗ |
| Alland Leila | Chief Medical Officer | M Exercise | 2021-08-09 | 2021-08-10 | 4,000 | $3.90 | $15.6K | 4,000 | SEC↗ |
| Alland Leila | Chief Medical Officer | S Sale | 2021-08-09 | 2021-08-10 | 224 | $36.69 | $8.2K | 0 | SEC↗ |
| Alland Leila | Chief Medical Officer | S Sale | 2021-08-09 | 2021-08-10 | 2,049 | $32.66 | $66.9K | 224 | SEC↗ |
| Alland Leila | Chief Medical Officer | S Sale | 2021-08-09 | 2021-08-10 | 2,198 | $35.06 | $77.1K | 1,802 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-06 | 2021-08-09 | 19,700 | $36.61 | $721.2K | 1,839,824 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-06 | 2021-08-09 | 200 | $36.94 | $7.4K | 1,839,624 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-05 | 2021-08-09 | 26,871 | $36.38 | $977.6K | 1,868,264 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-05 | 2021-08-09 | 8,740 | $36.70 | $320.8K | 1,859,524 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-04 | 2021-08-04 | 1,760 | $34.21 | $60.2K | 1,946,235 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-04 | 2021-08-04 | 28,676 | $36.22 | $1.04M | 1,900,384 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-04 | 2021-08-04 | 17,175 | $35.10 | $602.8K | 1,929,060 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-04 | 2021-08-04 | 5,249 | $36.80 | $193.2K | 1,895,135 | SEC↗ |
| Kung Winston | COO, CFO | M Exercise deriv | 2021-08-03 | 2021-08-04 | 4,500 | — | $0 | 219,034 | SEC↗ |
| Kung Winston | COO, CFO | S Sale | 2021-08-03 | 2021-08-04 | 4,500 | $33.82 | $152.2K | 1,600 | SEC↗ |
| Kung Winston | COO, CFO | M Exercise | 2021-08-03 | 2021-08-04 | 4,500 | $3.22 | $14.5K | 6,100 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-03 | 2021-08-04 | 100 | $34.74 | $3.5K | 1,947,995 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-03 | 2021-08-04 | 30,145 | $33.80 | $1.02M | 1,948,095 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-08-02 | 2021-08-04 | 13,031 | $34.74 | $452.7K | 1,978,240 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-07-29 | 2021-07-30 | 2,300 | $35.73 | $82.2K | 1,991,271 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-07-28 | 2021-07-30 | 8,724 | $35.76 | $312.0K | 1,993,571 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-07-27 | 2021-07-27 | 535 | $35.61 | $19.1K | 2,002,295 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-07-26 | 2021-07-27 | 4,839 | $35.73 | $172.9K | 2,002,830 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-07-23 | 2021-07-27 | 11,988 | $36.00 | $431.6K | 2,007,669 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-07-22 | 2021-07-23 | 200 | $35.61 | $7.1K | 2,019,657 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise deriv | 2021-07-21 | 2021-07-22 | 26,767 | — | $0 | 447,074 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise | 2021-07-21 | 2021-07-22 | 26,767 | $0.53 | $14.2K | 39,237 | SEC↗ |
| Mack David Henry | President and CEO | S Sale | 2021-07-21 | 2021-07-22 | 26,767 | $35.76 | $957.2K | 12,470 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-07-21 | 2021-07-23 | 18,672 | $35.82 | $668.8K | 2,019,857 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise deriv | 2021-07-20 | 2021-07-22 | 1,029 | — | $0 | 473,841 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise | 2021-07-20 | 2021-07-22 | 1,029 | $0.53 | $545 | 13,499 | SEC↗ |
| Mack David Henry | President and CEO | S Sale | 2021-07-20 | 2021-07-22 | 1,029 | $35.53 | $36.6K | 12,470 | SEC↗ |
| LEVINE ARNOLD J | Director | S Sale | 2021-07-20 | 2021-07-22 | 3,500 | $35.12 | $122.9K | 416,842 | SEC↗ |
| Kliman Gilbert H | 10% Owner | J Other | 2021-07-13 | 2021-07-14 | 500,000 | — | $0 | 4,469,911 | SEC↗ |
| Kliman Gilbert H | 10% Owner | J Other | 2021-07-13 | 2021-07-14 | 22,148 | — | $0 | 25,552 | SEC↗ |
| Kliman Gilbert H | 10% Owner | J Other | 2021-07-13 | 2021-07-14 | 2,441 | — | $0 | 2,816 | SEC↗ |
| Kliman Gilbert H | 10% Owner | J Other | 2021-07-13 | 2021-07-14 | 3,642 | — | $0 | 4,201 | SEC↗ |
| Kliman Gilbert H | 10% Owner | J Other | 2021-07-13 | 2021-07-14 | 97,632 | — | $0 | 0 | SEC↗ |
| Kliman Gilbert H | 10% Owner | J Other | 2021-07-13 | 2021-07-14 | 97,632 | — | $0 | 97,632 | SEC↗ |
| Kung Winston | COO, CFO | M Exercise deriv | 2021-07-08 | 2021-07-08 | 4,500 | — | $0 | 223,534 | SEC↗ |
| Kung Winston | COO, CFO | S Sale | 2021-07-08 | 2021-07-08 | 4,500 | $33.75 | $151.9K | 1,600 | SEC↗ |
| Kung Winston | COO, CFO | M Exercise | 2021-07-08 | 2021-07-08 | 4,500 | $3.22 | $14.5K | 6,100 | SEC↗ |
| Alland Leila | Chief Medical Officer | M Exercise deriv | 2021-07-07 | 2021-07-08 | 4,000 | — | $0 | 361,850 | SEC↗ |
| Alland Leila | Chief Medical Officer | M Exercise | 2021-07-07 | 2021-07-08 | 4,000 | $3.90 | $15.6K | 4,000 | SEC↗ |
| Alland Leila | Chief Medical Officer | S Sale | 2021-07-07 | 2021-07-08 | 1,951 | $31.93 | $62.3K | 2,049 | SEC↗ |
| Alland Leila | Chief Medical Officer | S Sale | 2021-07-07 | 2021-07-08 | 2,049 | $32.66 | $66.9K | 0 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise deriv | 2021-06-28 | 2021-06-29 | 204 | — | $0 | 474,870 | SEC↗ |
| Mack David Henry | President and CEO | S Sale | 2021-06-28 | 2021-06-29 | 204 | $35.53 | $7.2K | 12,470 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise | 2021-06-28 | 2021-06-29 | 204 | $0.53 | $108 | 12,674 | SEC↗ |
| LEVINE ARNOLD J | Director | S Sale | 2021-06-21 | 2021-06-22 | 3,389 | $33.22 | $112.6K | 420,453 | SEC↗ |
| LEVINE ARNOLD J | Director | S Sale | 2021-06-21 | 2021-06-22 | 111 | $34.09 | $3.8K | 420,342 | SEC↗ |
| Greenland A LLC | 10% Owner | S Sale | 2021-06-14 | 2021-06-15 | 24,726 | $34.11 | $843.4K | 2,496,554 | SEC↗ |
| Greenland A LLC | 10% Owner | S Sale | 2021-06-14 | 2021-06-15 | 7,141 | $34.11 | $243.6K | 720,999 | SEC↗ |
| Greenland A LLC | 10% Owner | S Sale | 2021-06-14 | 2021-06-15 | 6,593 | $34.11 | $224.9K | 665,696 | SEC↗ |
| Greenland A LLC | 10% Owner | S Sale | 2021-06-14 | 2021-06-15 | 4,699 | $34.11 | $160.3K | 474,363 | SEC↗ |
| Greenland A LLC | 10% Owner | S Sale | 2021-06-14 | 2021-06-15 | 1,260 | $34.11 | $43.0K | 127,099 | SEC↗ |
| Greenland A LLC | 10% Owner | S Sale | 2021-06-11 | 2021-06-15 | 621 | $33.80 | $21.0K | 128,359 | SEC↗ |
| Greenland A LLC | 10% Owner | S Sale | 2021-06-11 | 2021-06-15 | 12,237 | $33.80 | $413.6K | 2,521,280 | SEC↗ |
| Greenland A LLC | 10% Owner | S Sale | 2021-06-11 | 2021-06-15 | 3,533 | $33.80 | $119.4K | 728,140 | SEC↗ |
| Greenland A LLC | 10% Owner | S Sale | 2021-06-11 | 2021-06-15 | 3,262 | $33.80 | $110.3K | 672,289 | SEC↗ |
| Greenland A LLC | 10% Owner | S Sale | 2021-06-11 | 2021-06-15 | 2,324 | $33.80 | $78.6K | 479,062 | SEC↗ |
| Greenland NFP LLC | 10% Owner | S Sale | 2021-06-10 | 2021-06-11 | 11,485 | $32.68 | $375.3K | 2,533,517 | SEC↗ |
| Greenland NFP LLC | 10% Owner | S Sale | 2021-06-10 | 2021-06-11 | 3,317 | $32.68 | $108.4K | 731,673 | SEC↗ |
| Greenland NFP LLC | 10% Owner | S Sale | 2021-06-10 | 2021-06-11 | 3,063 | $32.68 | $100.1K | 675,551 | SEC↗ |
| Greenland NFP LLC | 10% Owner | S Sale | 2021-06-10 | 2021-06-11 | 2,183 | $32.68 | $71.3K | 481,386 | SEC↗ |
| Greenland NFP LLC | 10% Owner | S Sale | 2021-06-10 | 2021-06-11 | 585 | $32.68 | $19.1K | 129,980 | SEC↗ |
| Greenland NFP LLC | 10% Owner | S Sale | 2021-06-09 | 2021-06-11 | 1,121 | $33.64 | $37.7K | 129,565 | SEC↗ |
| Greenland NFP LLC | 10% Owner | S Sale | 2021-06-09 | 2021-06-11 | 22,070 | $33.64 | $742.4K | 2,545,002 | SEC↗ |
| Greenland NFP LLC | 10% Owner | S Sale | 2021-06-09 | 2021-06-11 | 6,372 | $33.64 | $214.4K | 734,990 | SEC↗ |
| Greenland NFP LLC | 10% Owner | S Sale | 2021-06-09 | 2021-06-11 | 5,883 | $33.64 | $197.9K | 678,614 | SEC↗ |
| Greenland NFP LLC | 10% Owner | S Sale | 2021-06-09 | 2021-06-11 | 4,192 | $33.64 | $141.0K | 483,569 | SEC↗ |
| Simons Marilyn | 10% Owner | S Sale | 2021-06-08 | 2021-06-09 | 3,355 | $33.38 | $112.0K | 487,761 | SEC↗ |
| Simons Marilyn | 10% Owner | S Sale | 2021-06-08 | 2021-06-09 | 4,708 | $33.38 | $157.2K | 684,497 | SEC↗ |
| Simons Marilyn | 10% Owner | S Sale | 2021-06-08 | 2021-06-09 | 5,101 | $33.38 | $170.3K | 741,362 | SEC↗ |
| Simons Marilyn | 10% Owner | S Sale | 2021-06-08 | 2021-06-09 | 17,664 | $33.38 | $589.6K | 2,567,072 | SEC↗ |
| Simons Marilyn | 10% Owner | S Sale | 2021-06-08 | 2021-06-09 | 896 | $33.38 | $29.9K | 130,686 | SEC↗ |
| Alland Leila | Chief Medical Officer | M Exercise deriv | 2021-06-07 | 2021-06-08 | 4,000 | — | $0 | 365,850 | SEC↗ |
| Alland Leila | Chief Medical Officer | S Sale | 2021-06-07 | 2021-06-08 | 2,633 | $33.39 | $87.9K | 1,367 | SEC↗ |
| Alland Leila | Chief Medical Officer | S Sale | 2021-06-07 | 2021-06-08 | 1,367 | $34.00 | $46.5K | 0 | SEC↗ |
| Alland Leila | Chief Medical Officer | M Exercise | 2021-06-07 | 2021-06-08 | 4,000 | $3.90 | $15.6K | 4,000 | SEC↗ |
| Simons Marilyn | 10% Owner | S Sale | 2021-06-07 | 2021-06-09 | 4,564 | $33.62 | $153.4K | 689,205 | SEC↗ |
| Simons Marilyn | 10% Owner | S Sale | 2021-06-07 | 2021-06-09 | 3,291 | $33.62 | $110.6K | 491,116 | SEC↗ |
| Simons Marilyn | 10% Owner | S Sale | 2021-06-07 | 2021-06-09 | 4,946 | $33.62 | $166.3K | 746,463 | SEC↗ |
| Simons Marilyn | 10% Owner | S Sale | 2021-06-07 | 2021-06-09 | 16,901 | $33.62 | $568.2K | 2,584,736 | SEC↗ |
| Simons Marilyn | 10% Owner | S Sale | 2021-06-07 | 2021-06-09 | 1,019 | $33.62 | $34.3K | 131,582 | SEC↗ |
| Kung Winston | COO, CFO | M Exercise deriv | 2021-06-04 | 2021-06-07 | 4,500 | — | $0 | 228,034 | SEC↗ |
| Kung Winston | COO, CFO | S Sale | 2021-06-04 | 2021-06-07 | 4,500 | $33.75 | $151.9K | 1,600 | SEC↗ |
| Kung Winston | COO, CFO | M Exercise | 2021-06-04 | 2021-06-07 | 4,500 | $3.22 | $14.5K | 6,100 | SEC↗ |
| BAUM CHARLES M | Director | A Award deriv | 2021-06-02 | 2021-06-09 | 16,333 | — | $0 | 16,333 | SEC↗ |
| Heyman Richard A. | Director | A Award deriv | 2021-06-02 | 2021-06-09 | 16,333 | — | $0 | 16,333 | SEC↗ |
| LEVINE ARNOLD J | Director | A Award deriv | 2021-06-02 | 2021-06-09 | 16,333 | — | $0 | 16,333 | SEC↗ |
| Stelzer Laurie | Director | A Award deriv | 2021-06-02 | 2021-06-09 | 16,333 | — | $0 | 16,333 | SEC↗ |
| Heyman Richard A. | Director | M Exercise deriv | 2021-06-01 | 2021-06-02 | 1,950 | — | $0 | 15,901 | SEC↗ |
| Heyman Richard A. | Director | M Exercise deriv | 2021-06-01 | 2021-06-02 | 975 | — | $0 | 7,951 | SEC↗ |
| Heyman Richard A. | Director | M Exercise deriv | 2021-06-01 | 2021-06-02 | 975 | — | $0 | 7,951 | SEC↗ |
| Heyman Richard A. | Director | S Sale | 2021-06-01 | 2021-06-02 | 1,392 | $32.15 | $44.8K | 558 | SEC↗ |
| Heyman Richard A. | Director | M Exercise | 2021-06-01 | 2021-06-02 | 975 | $975.00 | $950.6K | 975 | SEC↗ |
| Heyman Richard A. | Director | S Sale | 2021-06-01 | 2021-06-02 | 764 | $32.15 | $24.6K | 211 | SEC↗ |
| Heyman Richard A. | Director | S Sale | 2021-06-01 | 2021-06-02 | 209 | $33.79 | $7.1K | 2 | SEC↗ |
| Heyman Richard A. | Director | S Sale | 2021-06-01 | 2021-06-02 | 2 | $34.67 | $69 | 0 | SEC↗ |
| Heyman Richard A. | Director | M Exercise | 2021-06-01 | 2021-06-02 | 1,950 | $2.95 | $5.8K | 1,950 | SEC↗ |
| Heyman Richard A. | Director | S Sale | 2021-06-01 | 2021-06-02 | 2 | $34.67 | $69 | 0 | SEC↗ |
| Heyman Richard A. | Director | S Sale | 2021-06-01 | 2021-06-02 | 743 | $32.16 | $23.9K | 232 | SEC↗ |
| Heyman Richard A. | Director | M Exercise | 2021-06-01 | 2021-06-02 | 975 | $2.95 | $2.9K | 975 | SEC↗ |
| Heyman Richard A. | Director | S Sale | 2021-06-01 | 2021-06-02 | 5 | $34.67 | $173 | 0 | SEC↗ |
| Heyman Richard A. | Director | S Sale | 2021-06-01 | 2021-06-02 | 553 | $33.61 | $18.6K | 5 | SEC↗ |
| Heyman Richard A. | Director | S Sale | 2021-06-01 | 2021-06-02 | 230 | $33.75 | $7.8K | 2 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-05-28 | 2021-06-02 | 5,100 | $35.80 | $182.6K | 2,038,529 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-05-26 | 2021-05-27 | 7,487 | $35.66 | $267.0K | 2,043,629 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-05-25 | 2021-05-27 | 8,518 | $35.91 | $305.9K | 2,051,116 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-05-24 | 2021-05-24 | 22,095 | $36.03 | $796.1K | 2,059,634 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise deriv | 2021-05-21 | 2021-05-24 | 6,207 | — | $0 | 485,074 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise deriv | 2021-05-21 | 2021-06-04 | 10,000 | — | $0 | 475,074 | SEC↗ |
| Mack David Henry | President and CEO | S Sale | 2021-05-21 | 2021-05-24 | 6,207 | $35.71 | $221.7K | 2,470 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise | 2021-05-21 | 2021-05-24 | 6,207 | $0.53 | $3.3K | 8,677 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-05-21 | 2021-05-24 | 19,774 | $35.84 | $708.7K | 2,081,729 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise deriv | 2021-05-20 | 2021-05-24 | 7,793 | — | $0 | 492,867 | SEC↗ |
| LEVINE ARNOLD J | Director | S Sale | 2021-05-20 | 2021-05-21 | 2,961 | $34.68 | $102.7K | 423,842 | SEC↗ |
| LEVINE ARNOLD J | Director | S Sale | 2021-05-20 | 2021-05-21 | 539 | $33.57 | $18.1K | 426,803 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise | 2021-05-20 | 2021-05-24 | 7,793 | $0.53 | $4.1K | 10,263 | SEC↗ |
| Mack David Henry | President and CEO | S Sale | 2021-05-20 | 2021-05-24 | 7,793 | $35.60 | $277.4K | 2,470 | SEC↗ |
| Schroeder Thilo | Director | S Sale | 2021-05-20 | 2021-05-24 | 2,911 | $35.65 | $103.8K | 2,101,503 | SEC↗ |
| Mack David Henry | President and CEO | M Exercise | 2021-05-20 | 2021-06-04 | 10,000 | $0.53 | $5.3K | 12,470 | SEC↗ |
| LEVINE ARNOLD J | Director | A Award deriv | 2021-05-12 | 2021-07-22 | 5,781 | — | $0 | 5,781 | SEC↗ |